ARCT icon

Arcturus Therapeutics
ARCT

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$7
17% downside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citigroup
Citigroup
Yigal Nochomovitz
100% 1-yr ARCT win rate
6 Jan ‘26 1 month ago